Literature DB >> 35877097

Exposing the Two Contrasting Faces of STAT2 in Inflammation.

Philip Duodu1, Geohaira Sosa1, Jorge Canar1, Olivia Chhugani1, Ana M Gamero1.   

Abstract

Inflammation is a natural immune defense mechanism of the body's response to injury, infection, and other damaging triggers. Uncontrolled inflammation may become chronic and contribute to a range of chronic inflammatory diseases. Signal transducer and activator of transcription 2 (STAT2) is an essential transcription factor exclusive to type I and type III interferon (IFN) signaling pathways. Both pathways are involved in multiple biological processes, including powering the immune system as a means of controlling infection that must be tightly regulated to offset the development of persistent inflammation. While studies depict STAT2 as protective in promoting host defense, new evidence is accumulating that exposes the deleterious side of STAT2 when inappropriately regulated, thus prompting its reevaluation as a signaling molecule with detrimental effects in human disease. This review aims to provide a comprehensive summary of the findings based on literature regarding the inflammatory behavior of STAT2 in microbial infections, cancer, autoimmune, and inflammatory diseases. In conveying the extent of our knowledge of STAT2 as a proinflammatory mediator, the aim of this review is to stimulate further investigations into the role of STAT2 in diseases characterized by deregulated inflammation and the mechanisms responsible for triggering severe responses.

Entities:  

Keywords:  STAT2; asthma; bacterial; cancer; inflammation; interferon; viral

Mesh:

Substances:

Year:  2022        PMID: 35877097      PMCID: PMC9527059          DOI: 10.1089/jir.2022.0117

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   3.657


  141 in total

1.  Interferon Lambda Inhibits Bacterial Uptake during Influenza Superinfection.

Authors:  Helen E Rich; Collin C McCourt; Wen Quan Zheng; Kevin J McHugh; Keven M Robinson; Jieru Wang; John F Alcorn
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

Review 2.  The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.

Authors:  Katarzyna Blaszczyk; Hanna Nowicka; Kaja Kostyrko; Aleksandra Antonczyk; Joanna Wesoly; Hans A R Bluyssen
Journal:  Cytokine Growth Factor Rev       Date:  2016-03-18       Impact factor: 7.638

Review 3.  Association of STAT6 variants with asthma risk: a systematic review and meta-analysis.

Authors:  Xubo Qian; Yuan Gao; Xiaohong Ye; Meiping Lu
Journal:  Hum Immunol       Date:  2014-06-19       Impact factor: 2.850

4.  Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.

Authors:  Marina Karaghiosoff; Ralf Steinborn; Pavel Kovarik; Gernot Kriegshäuser; Manuela Baccarini; Birgit Donabauer; Ursula Reichart; Thomas Kolbe; Christian Bogdan; Tomas Leanderson; David Levy; Thomas Decker; Mathias Müller
Journal:  Nat Immunol       Date:  2003-04-07       Impact factor: 25.606

5.  Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency.

Authors:  Florian Gothe; Jarmila Stremenova Spegarova; Catherine F Hatton; Helen Griffin; Thomas Sargent; Sally A Cowley; William James; Anna Roppelt; Anna Shcherbina; Fabian Hauck; Hugh T Reyburn; Christopher J A Duncan; Sophie Hambleton
Journal:  J Allergy Clin Immunol       Date:  2022-02-17       Impact factor: 14.290

6.  IFN-α-driven CCL2 production recruits inflammatory monocytes to infection site in mice.

Authors:  C D Conrady; M Zheng; N A Mandal; N van Rooijen; D J J Carr
Journal:  Mucosal Immunol       Date:  2012-06-13       Impact factor: 7.313

7.  Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility.

Authors:  Xianyong Yin; Hui Qi Low; Ling Wang; Yonghong Li; Eva Ellinghaus; Jiali Han; Xavier Estivill; Liangdan Sun; Xianbo Zuo; Changbing Shen; Caihong Zhu; Anping Zhang; Fabio Sanchez; Leonid Padyukov; Joseph J Catanese; Gerald G Krueger; Kristina Callis Duffin; Sören Mucha; Michael Weichenthal; Stephan Weidinger; Wolfgang Lieb; Jia Nee Foo; Yi Li; Karseng Sim; Herty Liany; Ishak Irwan; Yikying Teo; Colin T S Theng; Rashmi Gupta; Anne Bowcock; Philip L De Jager; Abrar A Qureshi; Paul I W de Bakker; Mark Seielstad; Wilson Liao; Mona Ståhle; Andre Franke; Xuejun Zhang; Jianjun Liu
Journal:  Nat Commun       Date:  2015-04-23       Impact factor: 14.919

8.  Life-Threatening Influenza, Hemophagocytic Lymphohistiocytosis and Probable Vaccine-Strain Varicella in a Novel Case of Homozygous STAT2 Deficiency.

Authors:  Bishara J Freij; Aidan T Hanrath; Rui Chen; Sophie Hambleton; Christopher J A Duncan
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

9.  A Novel Case of Homozygous Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic Lymphohistiocytosis.

Authors:  Florian Gothe; Catherine F Hatton; Linh Truong; Zofia Klimova; Veronika Kanderova; Martina Fejtkova; Angela Grainger; Venetia Bigley; Joanna Perthen; Dipayan Mitra; Ales Janda; Eva Fronkova; Dusana Moravcikova; Sophie Hambleton; Christopher J A Duncan
Journal:  Clin Infect Dis       Date:  2022-01-07       Impact factor: 20.999

Review 10.  The type I interferonopathies: 10 years on.

Authors:  Yanick J Crow; Daniel B Stetson
Journal:  Nat Rev Immunol       Date:  2021-10-20       Impact factor: 108.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.